Back
Adtran Holdings 10K Form
Buy
69
ADTN
Adtran Holdings
Last Price:
$9.13
Seasonality Move:
-2.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | ADTN/Adtran Holdings Quarterly |
2023-08-14 | 10Q | ADTN/Adtran Holdings Quarterly |
2023-05-10 | 10Q | ADTN/Adtran Holdings Quarterly |
2022-11-09 | 10Q | ADTN/Adtran Holdings Quarterly |
2022-08-05 | 10Q | ADTN/Adtran Holdings Quarterly |
2022-05-06 | 10Q | ADTN/Adtran Holdings Quarterly |
Receive ADTN News And Ratings
See the #1 stock for the next 7 days that we like better than ADTN
ADTN Financial Statistics
Sales & Book Value
Annual Sales: | $922.7M |
---|---|
Cash Flow: | $24.5M |
Price / Cash Flow: | 18.35 |
Annual Sales: | $3.33 |
Price / Book: | 2.77 |
Profitability
EPS (TTM): | -1.71000 |
---|---|
Net Income (TTM): | $-147.3M |
Gross Margin: | $324.2M |
Return on Equity: | -22.59% |
Return on Assets: | -11.52% |
Adtran Holdings Earnings Forecast
Key Adtran Holdings Financial Ratios
-
The Gross Profit Margin over the past 32 years for ADTN is 35.13%.
-
The Selling, General & Administrative Expenses for ADTN have been equal to 25.24% of Gross Profit Margin.
-
The Research & Development expenses have been 24.00% of Revenue.
-
The Net Earning history of ADTN is -49.84% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 20 years.
Adtran Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Communications Equipment |
Sector: | Information Technology |
Current Symbol: | ADTN |
CUSIP: | 00738A |
Website: | adtran.com |
Debt
Debt-to-Equity Ratio: | 0.73 |
---|---|
Current Ratio: | 2.47 |
Quick Ratio: | 1.11 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 21.3 |
ADTN Technical Analysis vs Fundamental Analysis
Buy
69
Adtran Holdings (ADTN)
is a Buy
Is Adtran Holdings a Buy or a Sell?
-
Adtran Holdings stock is rated a BuyThe current Adtran Holdings [ADTN] share price is $9.20. The Score for ADTN is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.